These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8263310)

  • 41. Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood.
    Blundell JE; Campbell DB; Lesham M; Tozer R
    J Pharm Pharmacol; 1975 Mar; 27(3):187-92. PubMed ID: 238002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevation of Met5-enkephalin and beta-endorphin hypothalamic content in rats receiving anorectic drugs: differences between D-fenfluramine and D-amphetamine.
    Harsing LG; Yang HY; Govoni S; Costa E
    Neuropharmacology; 1982 Feb; 21(2):141-5. PubMed ID: 6278358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.
    Chait LD; Uhlenhuth EH; Johanson CE
    Psychopharmacology (Berl); 1986; 89(3):301-6. PubMed ID: 3088654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of fenfluramine-amphetamine combination on psychomotor activity].
    Brown CC
    Vie Med Can Fr; 1973; 2(2):148-56. PubMed ID: 4574871
    [No Abstract]   [Full Text] [Related]  

  • 45. Interactive effect of (plus or minus)-fenfluramine and (+)-amphetamine on feeding in rats.
    Leshem MB; Blundell JE
    J Pharm Pharmacol; 1974 Nov; 26(11):905-6. PubMed ID: 4156565
    [No Abstract]   [Full Text] [Related]  

  • 46. Cortisol and GH responses to D- and L-amphetamine in monkeys.
    Marantz R; Sachar EJ; Weitzman E; Sassin J
    Endocrinology; 1976 Aug; 99(2):459-65. PubMed ID: 954645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feeding parameters in the rat: interactions of chlordiazepoxide with (+)-amphetamine or fenfluramine [proceedings].
    Cooper SJ; Francis RL
    Br J Pharmacol; 1978 Nov; 64(3):378P-379P. PubMed ID: 719237
    [No Abstract]   [Full Text] [Related]  

  • 48. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonergic stimulation of adrenocorticotropin secretion in man.
    Lewis DA; Sherman BM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):458-62. PubMed ID: 6319452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of drug experience on drug induced conditioned taste aversions: studies with amphetamine and fenfluramine.
    Goudie AJ; Thornton EW
    Psychopharmacologia; 1975 Oct; 44(1):77-82. PubMed ID: 1239032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of d-amphetamine and fenfluramine on feeding pattens and activity of obese and lean Zucker rats.
    Grinker JA; Drewnowski A; Enns M; Kissileff H
    Pharmacol Biochem Behav; 1980 Feb; 12(2):265-75. PubMed ID: 7375488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between the anorexic actions of amphetamine and fenfluramine--possible effects on hunger and satiety.
    Blundell JE; Latham CJ; Leshem MB
    J Pharm Pharmacol; 1976 Jun; 28(6):471-7. PubMed ID: 7642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 54. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.
    Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL
    Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.
    Wachtel SR; Charnot A; de Wit H
    Psychopharmacology (Berl); 2001 Jan; 153(3):380-8. PubMed ID: 11271411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychomotor test performance with a fenfluramine-amphetamine combination.
    Brown CC; McAllister DR; Turek I
    J Clin Pharmacol; 1974 Jul; 14(7):369-76. PubMed ID: 4845393
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of the fenfluramine-induced serotonergic syndrome in rats subacutely treated with either saline or D-amphetamine.
    Hunsinger RN; Wilson MC
    Pharmacol Res Commun; 1984 Jun; 16(6):579-88. PubMed ID: 6463096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of acute d-amphetamine effects on thyrotropin release.
    Little KY; Garbutt JC; Mayo JP; Mason G
    Neuroendocrinology; 1988 Sep; 48(3):304-7. PubMed ID: 3141826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Open-field behavior after intravenous amphetamine analogues in rats.
    Lindquist MP; Götestam KG
    Psychopharmacology (Berl); 1977 Dec; 55(2):129-33. PubMed ID: 414270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.
    van Kammen DP; Schulz SC
    J Neural Transm; 1985; 64(1):35-43. PubMed ID: 4067601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.